查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1832516

速效气喘治疗市场报告：2031 年趋势、预测与竞争分析

Quick-Acting Asthma Medicine Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

由于医院药局、线上药局和零售药局市场蕴藏着机会，全球速效气喘药物市场前景光明。预计2025年至2031年，全球速效气喘药物市场的复合年增长率将达到5.1%。该市场的主要驱动力包括日益增长的医疗保健需求、慢性病盛行率的上升以及生物相似药和非专利气喘药物的兴起。

  • 根据 Lucintel 的预测，由于更精确的剂量控制和广泛的采用，平板电脑预计在预测期内将实现高速成长。
  • 从应用角度来看，医院药房由于对配药和库存管理具有高度的控制力，预计将实现最大的成长。
  • 按地区划分，北美预计将在预测期内实现最高成长，因为其拥有先进的医疗保健基础设施和日益普及的药品。

速效气喘药物市场的新趋势

速效气喘药物市场正经历一系列新兴趋势，这些趋势的驱动力包括技术进步、医疗服务模式的转变以及气喘盛行率的上升。这些趋势正在重塑气喘的治疗和管理方式，为产业相关人员带来挑战和机会。以下是一些正在改变市场的关键趋势：

  • 吸入器创新与设计：吸入器技术的进步显着改善了患者的治疗效果。呼吸驱动式吸入器和携带式设备日益普及，使患者能够更轻鬆、更准确地给药。这些创新也有助于减少用户用药量，进而提高服药顺从性。製造商越来越注重设计更容易使用、剂量更精准的吸入器，尤其针对儿童和老年人，改善整体气喘管理体验。
  • 生物相似药和学名药：生物相似药和学名药气喘药物的兴起使得速效治疗药物更加经济实惠，尤其是在新兴市场。随着某些关键气喘药物的专利到期，越来越多的学名药进入市场，为品牌药提供了经济高效的替代方案。这一趋势在印度和中国等地区尤其明显，因为这些地区的医疗成本在医疗保健的可近性方面起着重要作用。因此，更多患者能够获得控制气喘所需的药物，进而改善健康状况。
  • 数位健康整合：数位健康科技与气喘管理的整合正日益深入。行动应用程式、智慧吸入器和远端监控设备使患者能够即时追踪药物使用情况、气喘症状和诱因。这些技术使医疗服务提供者能够根据收集的患者数据量身定制治疗方案，从而提供更个人化、更快捷的照护。随着数位健康生态系统的发展，它将增强患者参与度，从而改善气喘管理和疗效。
  • 个人化医疗：个人化医疗正成为速效气喘药物市场的重要趋势，它能够根据每位患者的个别需求量身订做治疗方案。基因监测和生物标记识别技术的进步使得更精准的治疗方案能够将患者独特的气喘诱因和潜在遗传因素纳入考虑。这一趋势有望提高气喘治疗的有效性，减少副作用，并为难以接受传统治疗的患者提供更有针对性的缓解。
  • 政府措施与公共卫生宣传活动：世界各国政府日益重视气喘管理，并进行公共卫生宣传活动以提高公众意识，改善气喘治疗。促进早期诊断、更优药物治疗和预防措施的政策有助于减轻气喘的气喘负担。此外，全球为减少空气污染所做的努力也有助于改善气喘控制，减少气喘发作。这些努力对于气喘高发国家（例如中国和印度）尤其重要，因为政府的支持对于提高这些国家居民的医疗保健可近性至关重要。

吸入器创新、生物相似药、数位健康整合、个人化医疗以及政府措施等新兴趋势正在重塑速效气喘药物市场。这些趋势正在提高气喘治疗的可近性、有效性和可负担性，从而改善患者的治疗效果，并扩大全球市场。

速效气喘治疗市场的最新趋势

在配方、吸入器技术和监管支援的推动下，速效气喘药物市场正在经历重大的新兴市场发展。这些发展使全球气喘管理更加有效，也更加便利。以下是塑造市场的五个关键发展：

  • 新型复方吸入器的推出：一种新型复方吸入器，可在一台设备中同时输送支气管扩张剂和类固醇，正日益受到欢迎。这些吸入器提供更全面的治疗，并减少了对多种药物的需求。复方吸入器的出现使患者能够更有效地控制气喘症状，从而提高治疗顺从性和疗效。
  • 学名药和生物类似药的扩张：速效气喘药物市场正受益于学名药和生物相似药的推出。随着领先的气喘药物专利到期，这些价格实惠的替代药物正在扩大气喘基本治疗的可及性。学名药正在帮助满足日益增长的气喘治疗需求，尤其是在成本构成重大障碍的发展中地区。
  • 智慧吸入器的进步：配备数位感测器的智慧吸入器正在改变气喘管理。这些吸入器可以追踪使用情况，并向患者和医护人员提供即时回馈。透过帮助使用者坚持用药方案并追踪症状，智慧吸入器可以改善气喘控制并减少住院次数。这项技术在慢性气喘的管理以及在气喘发作期间提供及时介入方面尤其重要。
  • 更重视儿童气喘治疗：开发儿童专用气喘药物正日益受到重视。儿童气喘药物，例如适龄吸入器和低剂量製剂，正在帮助改善儿童患者的治疗效果。这些药物的设计旨在简化使用，并提高用药依从性，特别适用于难以使用传统吸入器的儿童。
  • 加速核准的监管支持：FDA 和 EMA 等监管机构越来越多地支持气喘药物的加速核准，尤其是创新治疗方法。这种支持有助于加速新治疗方法的获取，并改善患者的治疗选择。简化核准流程对于满足全球日益增长的气喘药物需求以及使新药更快进入市场至关重要。

速效气喘药物市场的最新发展，例如复方吸入器的推出、生物相似药的兴起、智慧吸入器技术以及支持性监管环境，正在重塑治疗格局。这些创新正在改善患者护理，提高药物的可及性，并推动市场成长。

目录

第一章执行摘要

第二章 市场概况

  • 背景和分类
  • 供应链

第三章：市场趋势及预测分析

  • 产业驱动力与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

4. 全球速效气喘治疗市场（按类型）

  • 概述
  • 按类型：吸引力分析
  • 平板电脑：趋势与预测（2019-2031）
  • 喷雾剂：趋势与预测（2019-2031）

5. 全球速效气喘治疗市场（依应用）

  • 概述
  • 依用途：吸引力分析
  • 医院药局：趋势与预测（2019-2031）
  • 网路药局：趋势与预测（2019-2031）
  • 零售药局：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031）

第六章区域分析

  • 概述
  • 按地区划分：速效气喘药物市场

7. 北美速效气喘药物市场

  • 概述
  • 北美速效气喘治疗市场（按类型）
  • 北美速效气喘治疗市场（依应用）
  • 美国速效气喘药物市场
  • 墨西哥速效气喘治疗市场
  • 加拿大速效气喘药物市场

8. 欧洲速效气喘药物市场

  • 概述
  • 欧洲速效气喘药物市场（按类型）
  • 欧洲速效气喘治疗市场（依应用）
  • 德国速效气喘药物市场
  • 法国速效气喘药物市场
  • 西班牙速效气喘药物市场
  • 义大利速效气喘治疗市场
  • 英国速效气喘药物市场

9. 亚太地区速效气喘药物市场

  • 概述
  • 亚太地区速效气喘治疗市场（按类型）
  • 亚太地区速效气喘治疗市场（依应用）
  • 日本速效气喘治疗市场
  • 印度速效气喘治疗市场
  • 中国速效气喘治疗市场
  • 韩国速效气喘治疗市场
  • 印尼速效气喘药物市场

第十章世界其他地区速效气喘治疗市场

  • 概述
  • 世界其他地区速效气喘治疗市场（按类型）
  • 世界其他地区速效气喘治疗市场（依应用）
  • 中东速效气喘治疗市场
  • 南美洲速效气喘治疗市场
  • 非洲速效气喘治疗市场

第11章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市占率分析

第十二章：机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按类型分類的成长机会
    • 按应用分類的成长机会
  • 全球速效气喘治疗市场的新趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 合併、收购、协议、合作和合资企业

第十三章 价值链主要企业的公司简介

  • Competitive Analysis
  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Merck
  • Boehringer Ingelheim

第十四章 附录

  • 图表目录
  • 表格列表
  • 调查方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于 Lucintel
  • 询问

The future of the global quick-acting asthma medicine market looks promising with opportunities in the hospital pharmacy, online pharmacy and retail pharmacy markets. The global quick-acting asthma medicine market is expected to grow with a CAGR of 5.1% from 2025 to 2031. The major drivers for this market are the growing need for healthcare, the increasing incidence of chronic diseases, and the rise of biosimilars and generic asthma medications.

  • Lucintel forecasts that, within the type category, tablet is expected to witness higher growth over the forecast period due to more precise dosage control and widespread use..
  • Within the application category, hospital pharmacy is expected to witness the highest growth due to greater control over medication dispensing and inventory management..
  • In terms of region, North America is expected to witness the highest growth over the forecast period due to advanced healthcare infrastructure and higher adoption of pharmaceutical products..

Emerging Trends in the Quick-Acting Asthma Medicine Market

The quick-acting asthma medicine market is experiencing a series of emerging trends, driven by technological advancements, shifts in healthcare delivery models, and the increasing prevalence of asthma. These trends are reshaping how asthma is treated and managed, offering both challenges and opportunities for industry stakeholders. Below are the key trends that are transforming the market:

  • Inhaler Innovation and Design: Advancements in inhaler technology are significantly improving patient outcomes. Breath-actuated inhalers and portable devices are becoming more common, making it easier for patients to administer their medication correctly and efficiently. These innovations are also contributing to better adherence, as they require less effort from the user. Manufacturers are increasingly focusing on designing inhalers that deliver precise doses while being more user-friendly, particularly for children and the elderly, thus improving the overall asthma management experience.
  • Biosimilars and Generic Medicines: The rise of biosimilars and generic asthma medications is making quick-acting treatments more affordable, especially in emerging markets. With the expiration of patents for certain key asthma drugs, more generic options are entering the market, offering a cost-effective alternative to brand-name medications. This trend is particularly evident in regions like India and China, where cost plays a major role in healthcare accessibility. As a result, more patients can access the medications they need to manage asthma, leading to improved health outcomes.
  • Digital Health Integration: The integration of digital health technologies into asthma management is gaining momentum. Mobile apps, smart inhalers, and remote monitoring devices are enabling patients to track their medication use, asthma symptoms, and triggers in real time. These technologies allow healthcare providers to offer more personalized and responsive care, adjusting treatments based on data collected from patients. As the digital health ecosystem grows, it enhances patient engagement, leading to better asthma management and outcomes.
  • Personalized Medicine: Personalized medicine is becoming an important trend in the quick-acting asthma medicine market, as treatments are increasingly being tailored to individual patient needs. Advances in genetic research and biomarker identification are enabling more precise therapies that consider a patient's specific asthma triggers and underlying genetic factors. This trend is expected to improve the effectiveness of asthma treatments, reduce side effects, and offer more targeted relief for patients who have previously struggled with conventional treatments.
  • Government Initiatives and Public Health Campaigns: Governments worldwide are becoming more involved in asthma management, launching public health campaigns to raise awareness and improve asthma care. Policies that promote early diagnosis, better medication access, and preventive measures are helping to reduce the overall burden of asthma. In addition, global efforts to reduce air pollution are contributing to improved asthma control and fewer exacerbations. These initiatives are especially important in countries with high asthma prevalence, such as China and India, where government support is crucial for enhancing healthcare access.

Emerging trends such as inhaler innovation, biosimilars, digital health integration, personalized medicine, and government initiatives are reshaping the quick-acting asthma medicine market. These trends are improving the accessibility, effectiveness, and affordability of asthma treatments, leading to better patient outcomes and expanding the market's global reach.

Recent Developments in the Quick-Acting Asthma Medicine Market

The quick-acting asthma medicine market is undergoing significant developments, driven by advancements in drug formulations, inhaler technologies, and regulatory support. These developments are making asthma management more effective and accessible for patients worldwide. Below are five key developments shaping the market:

  • Introduction of New Combination Inhalers: New combination inhalers that deliver both bronchodilators and steroids in a single device are gaining popularity. These inhalers offer a more comprehensive treatment, reducing the need for multiple medications. The availability of combination inhalers allows patients to manage their asthma symptoms more efficiently, leading to better treatment adherence and outcomes.
  • Expansion of Generic and Biosimilar Drugs: The market for quick-acting asthma medications is benefiting from the introduction of generic and biosimilar drugs. As patents for key asthma medications expire, these affordable alternatives are increasing access to essential asthma treatments. Generic and biosimilar medicines help address the growing demand for asthma care, particularly in developing regions where cost is a major barrier.
  • Advancements in Smart Inhalers: Smart inhalers equipped with digital sensors are transforming asthma management. These inhalers track usage and provide real-time feedback to patients and healthcare providers. By helping users adhere to their medication regimen and track symptoms, smart inhalers improve asthma control and reduce hospitalizations. This technology is especially valuable in managing chronic asthma and ensuring timely intervention during exacerbations.
  • Increased Focus on Pediatric Asthma Treatment: There has been a growing emphasis on developing asthma medicines tailored for children. Pediatric asthma treatments, including age-appropriate inhalers and lower-dose formulations, are helping to improve outcomes for young patients. These medications are designed to ensure ease of use and better adherence, particularly for children who may struggle with traditional inhaler devices.
  • Regulatory Support for Fast-track Approvals: Regulatory agencies, including the FDA and EMA, are increasingly supporting the fast-tracking of asthma medicine approvals, particularly for innovative treatments. This support enables quicker access to new therapies, improving treatment options for patients. Streamlined approval processes are crucial in addressing the growing global demand for asthma medicines, allowing for faster market entry of new drugs.

Recent developments in the quick-acting asthma medicine market, such as the introduction of combination inhalers, the rise of biosimilars, smart inhaler technologies, and regulatory support, are reshaping the treatment landscape. These innovations are improving patient care, increasing accessibility, and driving market growth.

Strategic Growth Opportunities in the Quick-Acting Asthma Medicine Market

The quick-acting asthma medicine market presents several strategic growth opportunities as the demand for effective asthma management grows globally. Key applications, including combination inhalers, digital health integration, and pediatric treatments, provide avenues for expansion. Below are five key growth opportunities across various applications in the market:

  • Combination Inhalers: Combination inhalers, which deliver both bronchodilators and corticosteroids, present a significant growth opportunity in asthma treatment. These inhalers simplify asthma management by reducing the need for multiple medications. The growing demand for more convenient and efficient treatment options, particularly among patients with moderate to severe asthma, is driving the growth of this segment. Manufacturers can capitalize on this trend by developing new combinations that target a broader range of symptoms.
  • Smart Inhalers: Smart inhalers equipped with digital technology are expected to revolutionize asthma management. These devices enable real-time monitoring and tracking of medication adherence, allowing for better management of asthma symptoms. With the integration of mobile apps and sensors, smart inhalers can improve patient engagement and enhance overall treatment effectiveness. As healthcare systems embrace digital health solutions, this segment is poised for rapid growth.
  • Pediatric Asthma Medicines: The pediatric asthma segment offers significant growth potential as the prevalence of asthma among children continues to rise. Developing medications and inhalers tailored for young patients, including age-appropriate doses and easier-to-use devices, is a key area for expansion. Companies focusing on pediatric asthma treatments will benefit from addressing unmet needs in this demographic and improving adherence to treatment protocols.
  • Biosimilars and Generic Medicines: The increasing demand for cost-effective asthma medications presents a growth opportunity for biosimilars and generics. With the expiration of patents for major asthma drugs, the introduction of lower-cost alternatives is expanding market access, particularly in emerging markets. Pharmaceutical companies that invest in biosimilars and generic medicines can tap into a large and growing patient base, driving market penetration in cost-sensitive regions.
  • Global Expansion into Emerging Markets: Emerging markets, particularly in Asia and Africa, present significant growth opportunities for quick-acting asthma medicines. As healthcare infrastructure improves in these regions and asthma awareness increases, demand for effective asthma treatments is rising. Companies that focus on expanding their reach into these markets will benefit from a larger customer base and increased revenue potential.

Strategic growth opportunities in the quick-acting asthma medicine market include the development of combination inhalers, the rise of smart inhalers, pediatric asthma treatments, biosimilars, and global expansion into emerging markets. These opportunities are set to drive market growth and provide innovative solutions for asthma management.

Quick-Acting Asthma Medicine Market Driver and Challenges

The quick-acting asthma medicine market is shaped by various drivers and challenges, driven by technological, economic, and regulatory factors. Understanding these forces is essential for companies looking to capitalize on the growing demand for asthma treatments. Below are the major drivers and challenges impacting the market.

The factors responsible for driving the Quick-acting Asthma Medicine market include:

1. Technological Advancements in Drug Delivery Systems: Technological advancements in inhaler design and drug delivery systems are one of the key drivers for the quick-acting asthma medicine market. The development of more efficient inhalers, such as breath-actuated devices, is improving the accuracy and ease of medication delivery, leading to better patient outcomes and higher adherence to treatment protocols. These innovations are contributing to the market's expansion by offering enhanced solutions for asthma management.

2. Growing Prevalence of Asthma: The increasing prevalence of asthma, especially in urban areas with high pollution levels, is driving demand for quick-acting asthma medications. As more people are diagnosed with asthma, there is a higher need for effective and fast-acting treatments. The rising asthma rates, particularly in developing countries, are contributing to the growth of the asthma medicine market, as more patients seek immediate relief options.

3. Rising Healthcare Access and Awareness: Improved access to healthcare and greater awareness of asthma management are significant drivers for the market. As healthcare systems in emerging markets like India and China improve, more patients are able to access quick-acting asthma medicines. Public health campaigns and education on asthma management are also leading to better recognition and treatment of the condition, further fueling market growth.

4. Government Initiatives and Regulatory Support: Government initiatives to improve asthma care, along with favorable regulatory support for new asthma treatments, are playing a crucial role in the market's expansion. Regulatory agencies are expediting the approval process for innovative asthma medications, while government-funded health programs are improving patient access to effective treatments.

5. Investment in Research and Development: Increased investment in asthma-related research and development is driving innovation in the market. Pharmaceutical companies are working on new formulations, combination therapies, and smart inhalers, which are expected to improve treatment outcomes and reduce asthma-related hospitalizations. The continued focus on R&D will likely lead to more advanced and effective treatments for asthma.

Challenges in the Quick-acting Asthma Medicine market are:

1. High Cost of Treatment: The high cost of asthma medications, especially newer combination inhalers and biologics, remains a significant challenge. Although quick-acting medications are essential for managing asthma, their cost can limit access for many patients, particularly in low- and middle-income countries. Addressing this cost barrier is crucial for improving accessibility and patient adherence.

2. Regulatory Barriers: Despite regulatory support for new treatments, regulatory barriers and lengthy approval processes for asthma medicines remain a challenge. These hurdles can delay the availability of innovative treatments, hindering market growth and limiting patient access to new therapies. Companies must navigate these regulatory challenges to bring new products to market efficiently.

3. Side Effects and Safety Concerns: Safety concerns, particularly the side effects of certain asthma medications, pose challenges to market growth. While quick-acting medications offer immediate relief, they can cause side effects such as tremors or tachycardia. The need for better safety profiles and more personalized treatments is critical to ensuring patient safety and improving treatment compliance.

The quick-acting asthma medicine market is driven by technological innovations, increased asthma prevalence, rising healthcare access, and regulatory support. However, challenges such as high treatment costs, regulatory barriers, and safety concerns must be addressed to ensure continued growth and broader access to effective asthma treatments.

List of Quick-Acting Asthma Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies quick-acting asthma medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the quick-acting asthma medicine companies profiled in this report include-

  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Merck
  • Boehringer Ingelheim

Quick-Acting Asthma Medicine Market by Segment

The study includes a forecast for the global quick-acting asthma medicine market by type, application, and region.

Quick-Acting Asthma Medicine Market by Type [Value from 2019 to 2031]:

  • Tablet
  • Spray

Quick-Acting Asthma Medicine Market by Application [Value from 2019 to 2031]:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

Quick-Acting Asthma Medicine Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Quick-Acting Asthma Medicine Market

The quick-acting asthma medicine market is experiencing significant developments due to ongoing innovation, increased healthcare access, and growing asthma prevalence across the globe. These medicines are designed to relieve asthma symptoms promptly and effectively, making them essential in managing acute attacks. In key markets such as the United States, China, Germany, India, and Japan, advancements in drug formulations, inhaler technologies, and regulatory frameworks are reshaping the market landscape. Below is an overview of recent developments in these regions, highlighting important trends, regulatory changes, and emerging treatment options.

  • United States: In the United States, the quick-acting asthma medicine market has seen significant growth with the introduction of new inhalers and combination therapies. Medications like albuterol and levalbuterol, along with new combination products such as the EpiPen for emergency relief, are driving the market. The focus on innovative inhaler designs, such as breath-actuated devices, is enhancing the user experience, making treatment more efficient and effective. Additionally, regulatory support from the FDA for novel delivery systems is further expanding treatment options, providing patients with more personalized and accessible solutions for managing asthma.
  • China: In China, the quick-acting asthma medicine market is expanding rapidly due to rising air pollution, an increasing incidence of asthma, and greater healthcare access. Local pharmaceutical companies are advancing the development of generic asthma medications, making quick-acting inhalers more affordable. Recent regulatory changes have streamlined the approval process for asthma drugs, improving market availability. With an aging population and increased urbanization, demand for asthma medications is expected to continue to rise, while government policies are increasingly focused on improving public health infrastructure and ensuring timely access to essential asthma treatments.
  • Germany: Germany is a key player in the European quick-acting asthma medicine market, where new inhaler technologies and combination therapies are becoming more popular. Companies are developing inhalers that deliver more accurate dosages with less user effort, thus improving treatment adherence. Recent collaborations between pharmaceutical companies and healthcare providers have led to more efficient asthma management strategies. Germany's robust healthcare system and regulatory support for innovative medicines have fostered a favorable environment for the growth of new treatments and improved delivery mechanisms, contributing to a larger share of the European asthma market.
  • India: India is witnessing a surge in demand for quick-acting asthma medicines due to the rising prevalence of respiratory conditions, exacerbated by pollution and smoking. The market is seeing an increase in affordable inhalers, with both local and international companies introducing cost-effective solutions for asthma patients. Regulatory reforms and increased government funding for public health initiatives have made asthma treatments more accessible to the Indian population. Additionally, local manufacturers are working on improving inhaler design and drug formulations to offer better patient outcomes while addressing affordability concerns in the country's growing healthcare sector.
  • Japan: Japan's quick-acting asthma medicine market has been expanding with innovations in inhaler technologies and advancements in precision medicines. Japanese pharmaceutical companies are developing drugs that not only offer fast relief but also minimize side effects, such as those found in combination inhalers. Regulatory approvals for new treatments have been quick, contributing to a more diverse and effective market for asthma medications. The aging population in Japan is driving the demand for effective and user-friendly asthma treatments, while recent policy efforts are aimed at improving healthcare accessibility, ensuring timely delivery of medications to asthma patients across the country.

Features of the Global Quick-Acting Asthma Medicine Market

  • Market Size Estimates: Quick-acting asthma medicine market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Quick-acting asthma medicine market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Quick-acting asthma medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the quick-acting asthma medicine market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the quick-acting asthma medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the quick-acting asthma medicine market by type (tablet and spray), application (hospital pharmacy, online pharmacy, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Quick-Acting Asthma Medicine Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Tablet: Trends and Forecast (2019-2031)
  • 4.4 Spray: Trends and Forecast (2019-2031)

5. Global Quick-Acting Asthma Medicine Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital Pharmacy: Trends and Forecast (2019-2031)
  • 5.4 Online Pharmacy: Trends and Forecast (2019-2031)
  • 5.5 Retail Pharmacy: Trends and Forecast (2019-2031)
  • 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Quick-Acting Asthma Medicine Market by Region

7. North American Quick-Acting Asthma Medicine Market

  • 7.1 Overview
  • 7.2 North American Quick-Acting Asthma Medicine Market by type
  • 7.3 North American Quick-Acting Asthma Medicine Market by application
  • 7.4 United States Quick-Acting Asthma Medicine Market
  • 7.5 Mexican Quick-Acting Asthma Medicine Market
  • 7.6 Canadian Quick-Acting Asthma Medicine Market

8. European Quick-Acting Asthma Medicine Market

  • 8.1 Overview
  • 8.2 European Quick-Acting Asthma Medicine Market by type
  • 8.3 European Quick-Acting Asthma Medicine Market by application
  • 8.4 German Quick-Acting Asthma Medicine Market
  • 8.5 French Quick-Acting Asthma Medicine Market
  • 8.6 Spanish Quick-Acting Asthma Medicine Market
  • 8.7 Italian Quick-Acting Asthma Medicine Market
  • 8.8 United Kingdom Quick-Acting Asthma Medicine Market

9. APAC Quick-Acting Asthma Medicine Market

  • 9.1 Overview
  • 9.2 APAC Quick-Acting Asthma Medicine Market by type
  • 9.3 APAC Quick-Acting Asthma Medicine Market by application
  • 9.4 Japanese Quick-Acting Asthma Medicine Market
  • 9.5 Indian Quick-Acting Asthma Medicine Market
  • 9.6 Chinese Quick-Acting Asthma Medicine Market
  • 9.7 South Korean Quick-Acting Asthma Medicine Market
  • 9.8 Indonesian Quick-Acting Asthma Medicine Market

10. ROW Quick-Acting Asthma Medicine Market

  • 10.1 Overview
  • 10.2 ROW Quick-Acting Asthma Medicine Market by type
  • 10.3 ROW Quick-Acting Asthma Medicine Market by application
  • 10.4 Middle Eastern Quick-Acting Asthma Medicine Market
  • 10.5 South American Quick-Acting Asthma Medicine Market
  • 10.6 African Quick-Acting Asthma Medicine Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Quick-Acting Asthma Medicine Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Pfizer
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 GlaxoSmithKline
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Novartis
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Merck
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Boehringer Ingelheim
    • Company Overview
    • Quick-Acting Asthma Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Quick-Acting Asthma Medicine Market
  • Figure 2.1: Usage of Quick-Acting Asthma Medicine Market
  • Figure 2.2: Classification of the Global Quick-Acting Asthma Medicine Market
  • Figure 2.3: Supply Chain of the Global Quick-Acting Asthma Medicine Market
  • Figure 3.1: Driver and Challenges of the Quick-Acting Asthma Medicine Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Quick-Acting Asthma Medicine Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Quick-Acting Asthma Medicine Market ($B) by Type
  • Figure 4.3: Forecast for the Global Quick-Acting Asthma Medicine Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Tablet in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Spray in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 5.1: Global Quick-Acting Asthma Medicine Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Quick-Acting Asthma Medicine Market ($B) by Application
  • Figure 5.3: Forecast for the Global Quick-Acting Asthma Medicine Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Online Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Retail Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 5.7: Trends and Forecast for Others in the Global Quick-Acting Asthma Medicine Market (2019-2031)
  • Figure 6.1: Trends of the Global Quick-Acting Asthma Medicine Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Quick-Acting Asthma Medicine Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Quick-Acting Asthma Medicine Market by type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Quick-Acting Asthma Medicine Market ($B) by type (2019-2024)
  • Figure 7.3: Forecast for the North American Quick-Acting Asthma Medicine Market ($B) by type (2025-2031)
  • Figure 7.4: North American Quick-Acting Asthma Medicine Market by application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Quick-Acting Asthma Medicine Market ($B) by application (2019-2024)
  • Figure 7.6: Forecast for the North American Quick-Acting Asthma Medicine Market ($B) by application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.1: European Quick-Acting Asthma Medicine Market by type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Quick-Acting Asthma Medicine Market ($B) by type (2019-2024)
  • Figure 8.3: Forecast for the European Quick-Acting Asthma Medicine Market ($B) by type (2025-2031)
  • Figure 8.4: European Quick-Acting Asthma Medicine Market by application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Quick-Acting Asthma Medicine Market ($B) by application (2019-2024)
  • Figure 8.6: Forecast for the European Quick-Acting Asthma Medicine Market ($B) by application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.1: APAC Quick-Acting Asthma Medicine Market by type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Quick-Acting Asthma Medicine Market ($B) by type (2019-2024)
  • Figure 9.3: Forecast for the APAC Quick-Acting Asthma Medicine Market ($B) by type (2025-2031)
  • Figure 9.4: APAC Quick-Acting Asthma Medicine Market by application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Quick-Acting Asthma Medicine Market ($B) by application (2019-2024)
  • Figure 9.6: Forecast for the APAC Quick-Acting Asthma Medicine Market ($B) by application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 10.1: ROW Quick-Acting Asthma Medicine Market by type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Quick-Acting Asthma Medicine Market ($B) by type (2019-2024)
  • Figure 10.3: Forecast for the ROW Quick-Acting Asthma Medicine Market ($B) by type (2025-2031)
  • Figure 10.4: ROW Quick-Acting Asthma Medicine Market by application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Quick-Acting Asthma Medicine Market ($B) by application (2019-2024)
  • Figure 10.6: Forecast for the ROW Quick-Acting Asthma Medicine Market ($B) by application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Quick-Acting Asthma Medicine Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Quick-Acting Asthma Medicine Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Quick-Acting Asthma Medicine Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Quick-Acting Asthma Medicine Market by Type
  • Figure 12.2: Growth Opportunities for the Global Quick-Acting Asthma Medicine Market by Application
  • Figure 12.3: Growth Opportunities for the Global Quick-Acting Asthma Medicine Market by Region
  • Figure 12.4: Emerging Trends in the Global Quick-Acting Asthma Medicine Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Quick-Acting Asthma Medicine Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Quick-Acting Asthma Medicine Market by Region
  • Table 1.3: Global Quick-Acting Asthma Medicine Market Parameters and Attributes
  • Table 3.1: Trends of the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 3.2: Forecast for the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Quick-Acting Asthma Medicine Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 4.4: Trends of Tablet in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 4.5: Forecast for Tablet in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 4.6: Trends of Spray in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 4.7: Forecast for Spray in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Quick-Acting Asthma Medicine Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.4: Trends of Hospital Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.5: Forecast for Hospital Pharmacy in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.6: Trends of Online Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.7: Forecast for Online Pharmacy in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.8: Trends of Retail Pharmacy in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.9: Forecast for Retail Pharmacy in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 5.10: Trends of Others in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 5.11: Forecast for Others in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 7.1: Trends of the North American Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 7.2: Forecast for the North American Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various type in the North American Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various type in the North American Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various application in the North American Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various application in the North American Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.1: Trends of the European Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 8.2: Forecast for the European Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various type in the European Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various type in the European Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various application in the European Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various application in the European Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.1: Trends of the APAC Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 9.2: Forecast for the APAC Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various type in the APAC Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various type in the APAC Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various application in the APAC Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various application in the APAC Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 10.1: Trends of the ROW Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 10.2: Forecast for the ROW Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various type in the ROW Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various type in the ROW Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various application in the ROW Quick-Acting Asthma Medicine Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various application in the ROW Quick-Acting Asthma Medicine Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Quick-Acting Asthma Medicine Market (2019-2031)
  • Table 11.1: Product Mapping of Quick-Acting Asthma Medicine Suppliers Based on Segments
  • Table 11.2: Operational Integration of Quick-Acting Asthma Medicine Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Quick-Acting Asthma Medicine Revenue
  • Table 12.1: New Product Launches by Major Quick-Acting Asthma Medicine Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Quick-Acting Asthma Medicine Market